Syzygium cumini ameliorates insulin resistance and β-cell dysfunction via modulation of PPARγ, dyslipidemia, oxidative stress, and TNF-α in type 2 diabetic rats

Journal of Pharmacological Sciences

Volumn 119, Issue 3, 2012, Pages 203-213

  Sharma, Ashok Kumar ^a   Bharti, Saurabh ^a   Kumar, Rajiv ^a   Krishnamurthy, Bhaskar ^a   Bhatia, Jagriti ^a   Kumari, Santosh ^b   Arya, Dharamvir Singh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN AGRICULTURAL RESEARCH INSTITUTE   (India)

Author keywords

Insulin resistance; PPar ; Streptozotocin; Syzygium cumini; Type 2 diabete

Indexed keywords

CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE DISMUTASE; SYZYGIUM CUMINI EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ANTIDIABETIC AGENT; ANTIOXIDANT; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLANT EXTRACT; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIARRHEAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DYSLIPIDEMIA; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PLANT SEED; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; UPREGULATION; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECT; EUGENIA; EXPERIMENTAL DIABETES MELLITUS; HOMEOSTASIS; METABOLISM; OXIDATIVE STRESS; PANCREAS; PANCREAS ISLET; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; EUGENIA; FEMALE; GLUTATHIONE PEROXIDASE; HOMEOSTASIS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LIPIDS; MALE; OXIDATIVE STRESS; PANCREAS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864507193     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11184FP     Document Type: Article

References (30)

1. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;119:S10-S16.
2. De Silva NM, Frayling TM. Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits. Curr Opin Lipidol. 2010;21:44-50.
3. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-1119. (Pubitemid 40629025)
4. Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46:733-749.
5. Goldberg RB, Holman R, Drucker DJ. Management of type 2 diabetes. N Engl J Med. 2005;358:293-297.
6. Ohkita M, Kiso Y, Matsumura Y. Pharmacology in health foods: improvement of vascular endothelial function by French maritime pine bark extract (Flavangenol). J Pharmacol Sci. 2011; 115:461-465.
7. Zhao Q, Matsumoto K, Tsuneyama K, Tanaka K, Li F, Shibahara N, et al. Diabetes-induced central cholinergic neuronal loss and cognitive deficit are attenuated by tacrine and a Chinese herbal prescription, Kangen-Karyu: elucidation in type 2 diabetes db/db mice. J Pharmacol Sci. 2011;117:230-242.
8. Sharma B, Balomajumder C, Roy P. Hypoglycaemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats. Food Chem Toxicol. 2008;46:2376-2383.
9. Helmstadter A. Syzygium cumini (L.) SKEELS (Myrtaceae) against diabetes-125 years of research. Pharmazie. 2008;63: 91-101. (Pubitemid 351270877)
10. Grover JK, Yadav S, Vats V. Medicinal plants of India with antidiabetic potential. J Ethnopharmacol. 2002;81:81-100. (Pubitemid 34518472)
11. Monami M, Lamanna C, Marchionni N, Mannucci E. Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2008;79: 196-203.
12. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA. 2002;287:360-372. (Pubitemid 34256388)
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
14. Ohkawa H, Oohishi N, Yagi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358. (Pubitemid 9194347)
15. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium- deficient rat liver. Biochem Biophys Res Commun. 1976;71:952-958.
16. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press Inc; 1974. p. 673-685.
17. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47:469-474.
18. Bradford MM. A rapid and sensitive method for quantization of microgram quantities effects of age and caloric restriction. Anal Biochem. 1976;72:248-254.
19. Zhou J, Zhou S, Tang J, Zhang K, Guang L, Huang Y, et al. Protective effect of berberine on beta cells in streptozotocin-and high-carbohydrate/high- fat diet-induced diabetic rats. Eur J Pharmacol. 2009;606:262-268.
20. Dogukan A, Sahin N, Tuzcu M, Juturu V, Orhan C, Onderci M, et al. The Effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biol Trace Elem Res. 2009;131:124-132.
21. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52:313-320. (Pubitemid 41175991)
22. Anandharajan R, Jaiganesh S, Shankernarayanan NP, Viswakarma RA, Balakrishnan A. In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPARγ in L6 myotubles. Phytomedicine. 2006;13: 434-441. (Pubitemid 43728733)
23. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med. 2004;351: 1106-1118.
24. Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, Kumar N, et al. Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation. Nature. 2011; 477:477-481.
25. Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord. 2000;24:S23-S27.
26. Kim OS, Yun Su-Jin, Jung B, Lee HE, Hahm Dae-Hyun, Shim I, et al. Hypolipidemic effects of crude extract of adlay seed (Coix lachrymajobi var. mayuen) in obesity rat fed high fat diet: Relations of TNF-α and leptin mRNA expressions and serum lipid levels. Life Sci. 2004;75:1391-1404.
27. Ravi K, Rajasekaran S, Subramanian S. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats. Food Chem Toxicol. 2005;43:1433-1439. (Pubitemid 40894640)
28. Halliwell B, Gutteridge JMC. Free radicals and toxicology. In: Free radicals in biology and medicine. Oxford: Clarendon Press; 1997. p. 1-27.
29. Ravi K, Ramchandran B, Subramanian S. Effect of Eugenia jambolana seed kernel on antioxidant defense system in streptozotocin induced diabetes in rats. Life Sci. 2004;75:2717-2731. (Pubitemid 39215063)
30. Timbola AK, Szpoganicz B, Branco A, Monache FD, Pizzolatti MG. A new flavonol from leaves of Eugenia jambolana. Fitoterapia. 2002;73:174-176. (Pubitemid 34308932)